Abstract
Objectives
This study sought to characterize epileptic phenotypes in children with nonspecific mitochondrial disease (MD) and to evaluate MD diagnostic approaches.
Methods
A retrospective analysis of the medical, electroencephalogram, and laboratory records of 142 patients with epilepsy was performed. The patients were evaluated for MD, and 124 patients were included in the final cohort. The MD criteria used included an oral glucose lactate stimulation test (OGLST) and urine organic acid/plasma amino acid (UOA/PAA) assays as metabolic indicators of modified Walker criteria, as suggested by Bernier et al. (Neurology 59:1406–1411, 2002).
Results
Twenty-two patients were classified as having definite MD (9), probable MD (5), possible MD (6), or pyruvate dehydrogenase (PDH) deficiency (3), including one patient which showed a respiratory chain (RC) defect and PDH deficiency. Seven out of eight patients in whom significant RC defects were observed showed complex I defects. In 14 patients, epileptic seizures start at infantile ages. Of 17 patients who substantially presented generalized seizures, 4 patients started with partial seizures. Five patients consistently presented only partial seizures. The OGLST and UOA/PAA assays were useful for a more precise diagnosis of MD, although low positive predictive value of the OGLST was regrettable. No patient was classified as definite MD by Walker’s original criteria, but the use of our revised MD criteria resulted in the classification of nine additional patients as definite MD.
Conclusions
MD manifested considerable diverse epileptic phenotypes and should be considered in the differential diagnosis of epilepsy in children with unexplained encephalomyopathy and progressive and fluctuating clinical courses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Vu TH, Hirano M, Dimauro S (2002) Mitochondrial diseases. Neurol Clin 20:809–839
Schmiedel J, Jackson S, Schäfer J, Reichmann H (2003) Mitochondrial cytopathies. J Neurol 250:267–277
Berkovic F, Carpenter S, Evans A, et al. (1989) Myoclonus epilepsy and ragged-red fibers (MERRF). A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 112:1231–1260
Pavlakis SG, Philips PC, Dimauro S, et al. (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488
Walker UA, Collins S, Byrne E (1996) Respiratory chain encephalomyopathies: A diagnostic classification. Eur Neurol 36:260–267
Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR, (2002) Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 59:1406–1411
Chi CS, Mak SC, Shian WJ, Chen CH (1992) Oral glucose lactate stimulation test in mitochondrial diseases. Pediatr Neurol 8:445–449
Kang HC, Kim HD, Lee YM, Han SH (2006) Landau–Kleffner syndrome with mitochondrial respiratory chain-complex I deficiency. Pediatr Neurol 35:158–161
Kunz WS (2002) The role of mitochondria in epileptogenesis. Curr Opin Neurol 15:179–184
Haller RG, Lewis SF, Estabrook RW, DiMauro S, Servidei S, Foster DW (1989) Exercise intolerance, lactic acidosis and abnormal cardiopulmonary regulation in exercise associated with adult skeletal muscle cytochrome c oxidase deficiency. J Clin Invest 84:155–161
Wolf NI, Smeitink JAM (2002) Mitochondrial disorders. Neurology 59:1402–1405
Kirby DM, Crawford M, Cleary MA, Dahl HM, Dennett X, Thorburn DR (1999) Respiratory chain complex I deficiency. Neurology 52:1255–1264
Canafoglia L, Franceschetti S, Antozzi C, et al. (2001) Epileptic phenotypes associated with mitochondrial disorders. Neurology 56:1340–1346
Wada N, Matsuishi T, Nonaka M, Naito E, Yoshino M (2004) Pyruvate dehydrogenase E1α subunit deficiency in a female patient: evidence of antenatal origin of brain damage and possible etiology of infantile spasms. Brain Develop 26:57–60
Wexler ID, Hemalatha SG, McConnell J, et al. (1997) Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Neurology 49:1655–1661
Nordli DR Jr, DeVivo DC (2001) The ketogenic diet. In: Wyllie E (ed). The treatment of epilepsy, principles & practice, 3rd edn. Lippincott Williams & Wilkins Co., Philadelphia, pp 1001–1006
Santra S, Gilkerson RW, Davidson M, Schon EA (2004) Mitochondrial DNAs in cultured human cells. Ann Neurol 56:662–669
Scaglia F, Towbin JA, Craigen WJ et al. (2004) Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatr 114:925–931
Munnich A, Rötig A, Cormier-Daire V, Rustin P (2001) Clinical presentation of respiratory chain deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The metoblic & molecular bases of inherited disease, 8th edn. Lippincott McGraw-Hill Co., New York, pp 2261–2274
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the 2004 Inje University Research Grant.
Rights and permissions
About this article
Cite this article
Kang, HC., Kwon, J.W., Lee, Y.M. et al. Nonspecific mitochondrial disease with epilepsy in children: diagnostic approaches and epileptic phenotypes. Childs Nerv Syst 23, 1301–1307 (2007). https://doi.org/10.1007/s00381-007-0369-7
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-007-0369-7